Feb 26 |
Wall Street Analysts Predict a 52.78% Upside in Edgewise Therapeutics, Inc. (EWTX): Here's What You Should Know
|
Feb 22 |
Edgewise Therapeutics Non-GAAP EPS of $0.47
|
Feb 22 |
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
|
Feb 21 |
13 Best Booming Stocks to Buy Right Now
|
Feb 18 |
Edgewise Therapeutics: Behind The Massive Rally
|
Feb 13 |
Krystal Biotech, Candel, Edgewise gain after FDA fast track tags
|
Feb 13 |
Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)
|
Feb 9 |
Wall Street Analysts See a 33.27% Upside in Edgewise Therapeutics, Inc. (EWTX): Can the Stock Really Move This High?
|
Jan 31 |
How Is The Market Feeling About Edgewise Therapeutics?
|
Jan 26 |
Insiders Buying Edgewise Therapeutics And 2 Other Stocks
|